Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, LXRX, BGNE, WW, SGEN, and represent 30.80% of Artal Group's stock portfolio.
- Added to shares of these 10 stocks: C (+$46M), SRRK (+$35M), LABU (+$27M), FATE (+$15M), CYTK (+$11M), WVE (+$6.5M), CINC, Senti Biosciences Ord, SWTX, SELB.
- Started 7 new stock positions in BBWI, LABU, Senti Biosciences Ord, CINC, C, UNG, CLF.
- Reduced shares in these 10 stocks: ARGX (-$71M), SGEN (-$22M), PTGX (-$19M), SAGE (-$18M), MRTX (-$17M), INTC (-$15M), BLU (-$14M), APLS (-$10M), FMTX (-$9.3M), TGTX (-$7.6M).
- Sold out of its positions in APLS, Dynamics Special Purpose Cor, FMTX, DNA, IMCR, INTC, PTGX, TGTX, XP.
- Artal Group was a net seller of stock by $-80M.
- Artal Group has $1.9B in assets under management (AUM), dropping by -21.61%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Artal Group
Artal Group holds 134 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 8.1 | $152M | -31% | 400k | 378.88 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 7.1 | $132M | 71M | 1.86 | ||
| Beigene Sponsored Adr (BGNE) | 5.6 | $105M | -2% | 650k | 161.85 | |
| Ww Intl (WW) | 5.1 | $95M | 15M | 6.39 | ||
| Seagen (SGEN) | 5.0 | $93M | -19% | 525k | 176.94 | |
| Alnylam Pharmaceuticals (ALNY) | 4.7 | $88M | -7% | 600k | 145.85 | |
| Mirati Therapeutics (MRTX) | 3.9 | $74M | -18% | 1.1M | 67.13 | |
| Bellus Health Com New (BLU) | 3.5 | $65M | -17% | 7.0M | 9.24 | |
| Fate Therapeutics (FATE) | 3.4 | $64M | +30% | 2.6M | 24.78 | |
| Cytokinetics Com New (CYTK) | 2.7 | $50M | +27% | 1.3M | 39.29 | |
| Scholar Rock Hldg Corp (SRRK) | 2.6 | $48M | +257% | 8.8M | 5.49 | |
| Citigroup Com New Call Option (C) | 2.5 | $46M | NEW | 1.0M | 45.99 | |
| Amicus Therapeutics (FOLD) | 2.3 | $43M | 4.0M | 10.74 | ||
| Seer Com Cl A (SEER) | 2.3 | $43M | 4.8M | 8.95 | ||
Setup an alertArtal Group will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Cerevel Therapeutics Hldng I (CERE) | 2.1 | $40M | 1.5M | 26.44 | ||
| Igm Biosciences (IGMS) | 2.0 | $37M | +2% | 2.1M | 18.03 | |
| Morphic Hldg (MORF) | 1.9 | $36M | 1.7M | 21.70 | ||
| Krystal Biotech (KRYS) | 1.8 | $33M | 500k | 65.66 | ||
| Direxion Shs Etf Tr Sp Biotch Bl New Call Option (LABU) | 1.4 | $27M | NEW | 4.0M | 6.74 | |
| Foghorn Therapeutics (FHTX) | 1.2 | $23M | 1.7M | 13.60 | ||
| Springworks Therapeutics (SWTX) | 1.2 | $22M | +5% | 900k | 24.62 | |
| Gossamer Bio (GOSS) | 1.1 | $20M | 2.4M | 8.37 | ||
| Kymera Therapeutics (KYMR) | 1.1 | $20M | 1.0M | 19.69 | ||
| Kura Oncology (KURA) | 1.0 | $19M | 1.1M | 18.33 | ||
| Eqrx (EQRX) | 1.0 | $19M | 4.0M | 4.69 | ||
| Schrodinger (SDGR) | 1.0 | $19M | 700k | 26.41 | ||
| Generation Bio (GBIO) | 1.0 | $19M | 2.8M | 6.56 | ||
| Erasca (ERAS) | 0.9 | $18M | 3.2M | 5.57 | ||
| Denali Therapeutics (DNLI) | 0.9 | $18M | 600k | 29.43 | ||
| Replimune Group (REPL) | 0.8 | $16M | 900k | 17.48 | ||
| Sage Therapeutics (SAGE) | 0.8 | $15M | -55% | 450k | 32.30 | |
| Intellia Therapeutics (NTLA) | 0.8 | $14M | 275k | 51.76 | ||
| Evotec Sponsored Ads (EVO) | 0.7 | $14M | 1.1M | 11.98 | ||
| Relay Therapeutics (RLAY) | 0.6 | $12M | 700k | 16.75 | ||
| Mersana Therapeutics (MRSN) | 0.5 | $10M | 2.2M | 4.62 | ||
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $10M | 1.0M | 10.05 | ||
| Repare Therapeutics Ord (RPTX) | 0.5 | $9.8M | 700k | 13.99 | ||
| Wave Life Sciences SHS (WVE) | 0.5 | $9.8M | +200% | 3.0M | 3.25 | |
| I Mab Sponsored Ads (IMAB) | 0.5 | $9.6M | 850k | 11.30 | ||
| Talaris Therapeutics (TALS) | 0.5 | $9.3M | 2.1M | 4.51 | ||
| Allovir (ALVR) | 0.5 | $9.1M | 2.3M | 3.90 | ||
| Omega Therapeutics (OMGA) | 0.5 | $8.6M | 2.3M | 3.80 | ||
| Iteos Therapeutics (ITOS) | 0.4 | $8.2M | 400k | 20.60 | ||
| Atara Biotherapeutics (ATRA) | 0.4 | $7.8M | 1.0M | 7.79 | ||
| Omega Alpha Spac Cl A (OMEG) | 0.4 | $7.4M | 750k | 9.85 | ||
| Ikena Oncology (IKNA) | 0.4 | $6.9M | 1.5M | 4.43 | ||
| Selecta Biosciences (SELB) | 0.3 | $6.4M | +22% | 4.9M | 1.31 | |
| Verve Therapeutics (VERV) | 0.3 | $6.1M | 400k | 15.28 | ||
| Y Mabs Therapeutics (YMAB) | 0.3 | $6.1M | 400k | 15.13 | ||
| Exscientia Ads (EXAI) | 0.3 | $6.0M | 550k | 10.89 | ||
| Agenus Com New (AGEN) | 0.3 | $5.8M | -45% | 3.0M | 1.94 | |
| Ambrx Biopharma Sponsored Ads (AMAM) | 0.3 | $5.7M | 2.2M | 2.65 | ||
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $5.7M | 2.3M | 2.52 | ||
| Kronos Bio (KRON) | 0.3 | $5.6M | 1.5M | 3.64 | ||
| Design Therapeutics (DSGN) | 0.3 | $5.6M | 400k | 14.00 | ||
| Ovid Therapeutics (OVID) | 0.3 | $5.4M | 2.5M | 2.15 | ||
| Oatly Group Ab Sponsored Ads (OTLY) | 0.3 | $5.2M | 1.5M | 3.46 | ||
| Sqz Biotech (SQZ) | 0.3 | $5.1M | 1.6M | 3.18 | ||
| Alpine Immune Sciences (ALPN) | 0.3 | $5.0M | 593k | 8.51 | ||
| Marinus Pharmaceuticals Com New (MRNS) | 0.3 | $4.8M | 1.0M | 4.84 | ||
| Contrafect Corp Com New (CFRX) | 0.2 | $4.6M | 1.5M | 3.07 | ||
| Leap Therapeutics (LPTX) | 0.2 | $4.6M | 4.0M | 1.15 | ||
| Lyell Immunopharma (LYEL) | 0.2 | $4.6M | 700k | 6.52 | ||
| Black Diamond Therapeutics (BDTX) | 0.2 | $4.0M | 1.6M | 2.46 | ||
| Alx Oncology Hldgs (ALXO) | 0.2 | $4.0M | 500k | 8.09 | ||
| Taysha Gene Therapies Com Shs (TSHA) | 0.2 | $3.9M | 1.0M | 3.72 | ||
| Syros Pharmaceuticals (SYRS) | 0.2 | $3.9M | +14% | 4.0M | 0.96 | |
| Sea Sponsored Ads (SE) | 0.2 | $3.8M | 58k | 66.85 | ||
| Nanobiotix Sponsored Ads (NBTX) | 0.2 | $3.8M | 1.0M | 3.80 | ||
| Portage Fintech Acquisitn Class A Ord Shs (PFTA) | 0.2 | $3.7M | 380k | 9.75 | ||
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.2 | $3.7M | 450k | 8.14 | ||
| Avidity Biosciences Ord (RNA) | 0.2 | $3.6M | 250k | 14.53 | ||
| Ac Immune Sa SHS (ACIU) | 0.2 | $3.6M | 1.0M | 3.61 | ||
| Dyne Therapeutics (DYN) | 0.2 | $3.6M | 525k | 6.87 | ||
| Adverum Biotechnologies (ADVM) | 0.2 | $3.6M | 3.0M | 1.20 | ||
| Aptinyx (APTX) | 0.2 | $3.4M | 6.1M | 0.56 | ||
| Stoke Therapeutics (STOK) | 0.2 | $3.3M | 250k | 13.21 | ||
| Adagio Therapeutics (ADGI) | 0.2 | $3.3M | 1.0M | 3.28 | ||
| Cullinan Oncology (CGEM) | 0.2 | $3.2M | 250k | 12.82 | ||
| Rubius Therapeutics (RUBY) | 0.2 | $3.1M | 3.7M | 0.85 | ||
| Hookipa Pharma Inc equity (HOOK) | 0.2 | $3.0M | 1.8M | 1.63 | ||
| Praxis Precision Medicines I (PRAX) | 0.2 | $2.9M | 1.2M | 2.45 | ||
| Vigil Neuroscience (VIGL) | 0.2 | $2.9M | 1.1M | 2.58 | ||
| Mirion Technologies Com Cl A (MIR) | 0.2 | $2.9M | 500k | 5.76 | ||
| Vor Biopharma (VOR) | 0.1 | $2.7M | 550k | 4.97 | ||
| Cincor Pharma (CINC) | 0.1 | $2.6M | NEW | 137k | 18.84 | |
| Sana Biotechnology (SANA) | 0.1 | $2.6M | 400k | 6.43 | ||
| Immunic (IMUX) | 0.1 | $2.4M | 700k | 3.47 | ||
| Zymeworks (ZYME) | 0.1 | $2.4M | 450k | 5.30 | ||
| Bridgebio Pharma (BBIO) | 0.1 | $2.3M | 250k | 9.08 | ||
| Tcr2 Therapeutics Inc cs (TCRR) | 0.1 | $2.2M | 750k | 2.90 | ||
| Instil Bio (TIL) | 0.1 | $2.1M | 450k | 4.62 | ||
| Senti Biosciences Ord | 0.1 | $2.1M | NEW | 1.1M | 1.96 | |
| Adagene Ads (ADAG) | 0.1 | $2.1M | 1.0M | 2.07 | ||
| Immutep Sponsored Ads (IMMP) | 0.1 | $2.0M | 1.0M | 2.03 | ||
| 111 Ads (YI) | 0.1 | $2.0M | 966k | 2.06 | ||
| Neximmune (NEXI) | 0.1 | $1.9M | 1.2M | 1.61 | ||
| Graphite Bio (GRPH) | 0.1 | $1.9M | 700k | 2.75 | ||
| Harpoon Therapeutics (HARP) | 0.1 | $1.9M | 1.0M | 1.91 | ||
| Fusion Pharmaceuticals (FUSN) | 0.1 | $1.9M | 750k | 2.49 | ||
| Solid Biosciences (SLDB) | 0.1 | $1.8M | 3.0M | 0.62 | ||
| Gritstone Oncology Ord (GRTS) | 0.1 | $1.8M | 750k | 2.42 | ||
| Oric Pharmaceuticals (ORIC) | 0.1 | $1.8M | 400k | 4.48 | ||
| Mereo Biopharma Group Ads (MREO) | 0.1 | $1.7M | 1.5M | 1.12 | ||
| Cardiff Oncology (CRDF) | 0.1 | $1.7M | 750k | 2.20 | ||
| 23andme Holding Class A Com (ME) | 0.1 | $1.6M | 661k | 2.48 | ||
| Kinnate Biopharma (KNTE) | 0.1 | $1.6M | 125k | 12.61 | ||
| Cyclerion Therapeutics (CYCN) | 0.1 | $1.5M | 2.8M | 0.55 | ||
| Axcella Health Inc equity (AXLA) | 0.1 | $1.4M | 713k | 2.03 | ||
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.4M | 75k | 19.27 | ||
| Xilio Therapeutics (XLO) | 0.1 | $1.3M | 450k | 2.92 | ||
| Aravive (ARAV) | 0.1 | $1.3M | 1.3M | 0.99 | ||
| Curis Com New (CRIS) | 0.1 | $1.3M | 1.3M | 0.98 | ||
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.1 | $1.3M | 111k | 11.53 | ||
| Olema Pharmaceuticals (OLMA) | 0.1 | $1.1M | 261k | 4.07 | ||
| Orchard Therapeutics Ads (ORTX) | 0.1 | $1.1M | 1.8M | 0.58 | ||
| Mei Pharma Com New (MEIP) | 0.0 | $605k | 1.0M | 0.60 | ||
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $590k | 200k | 2.95 | ||
| Codiak Biosciences (CDAK) | 0.0 | $576k | 200k | 2.88 | ||
| Caribou Biosciences (CRBU) | 0.0 | $572k | 105k | 5.43 | ||
| Hippo Holdings (HIPO) | 0.0 | $527k | 600k | 0.88 | ||
| Corvus Pharmaceuticals (CRVS) | 0.0 | $495k | 500k | 0.99 | ||
| Metacrine Ord (MTCR) | 0.0 | $462k | 925k | 0.50 | ||
| Mink Therapeutics (INKT) | 0.0 | $408k | 290k | 1.41 | ||
| Yumanity Therapeutics (YMTX) | 0.0 | $396k | 217k | 1.82 | ||
| Cleveland-cliffs (CLF) | 0.0 | $384k | NEW | 25k | 15.36 | |
| United Sts Nat Gas Unit Par (UNG) | 0.0 | $380k | NEW | 20k | 19.00 | |
| Applied Therapeutics (APLT) | 0.0 | $379k | 400k | 0.95 | ||
| Spero Therapeutics (SPRO) | 0.0 | $371k | 500k | 0.74 | ||
| Bath & Body Works In (BBWI) | 0.0 | $337k | NEW | 13k | 26.96 | |
| Sigilon Therapeutics (SGTX) | 0.0 | $229k | 276k | 0.83 | ||
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $110k | 225k | 0.49 | ||
| Astria Therapeutics (ATXS) | 0.0 | $100k | 33k | 3.00 | ||
| Kaleido Biosciences Ord (KLDO) | 0.0 | $31k | 501k | 0.06 | ||
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2022 Q2 filed Aug. 11, 2022
- Artal Group 2022 Q1 filed May 12, 2022
- Artal Group 2021 Q4 filed Feb. 11, 2022
- Artal Group 2021 Q3 filed Nov. 12, 2021
- Artal Group 2021 Q2 filed Aug. 13, 2021
- Artal Group 2021 Q1 filed May 14, 2021
- Artal Group 2020 Q4 filed Feb. 11, 2021
- Artal Group 2020 Q3 filed Nov. 13, 2020
- Artal Group 2020 Q2 filed Aug. 14, 2020
- Artal Group 2020 Q1 filed May 14, 2020
- Artal Group 2019 Q4 filed Feb. 13, 2020
- Artal Group 2019 Q3 filed Nov. 14, 2019
- Artal Group 2019 Q2 filed Aug. 9, 2019
- Artal Group 2019 Q1 filed May 10, 2019
- Artal Group 2018 Q4 filed Feb. 11, 2019
- Artal Group 2018 Q3 filed Nov. 9, 2018